Skip to main content
    B

    Bruker Corporation (BRKR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $61.36
    +0.74 (+1.22%)

    Market Cap: $9.41B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Bruker Corporation (BRKR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Bruker (BRKR) has a market cap of $9.41B and an enterprise value of $11.00B. Its trailing P/E is 31.5x.

    Total Valuation

    Enterprise value is 16.94% above the market cap, as debt exceeds cash.

    Market Cap$9.41B
    Enterprise Value$11.00B
    Latest price (Nov 17, 2026)$61.36

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 21, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Last Ex-Dividend DateSep 21, 2026
    Last Payment DateOct 7, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.13% in the quarter ended Sep 30, 2026 and grew 0.33% a year over 2 years.

    Shares Outstanding152.50M
    Shares Change (YoY)+0.46%
    Shares Change (QoQ)+0.13%
    Share Count Growth (2Y CAGR)+0.33%

    Valuation Ratios

    The price to sales ratio is 2.7x. Its year-end P/E ranged from 17.8x to 40.1x from 2016 to 2025.

    P/E Ratio31.5x
    Forward P/E28.1x
    P/S Ratio2.7x
    Forward P/S2.7x
    P/FCF Ratio38.2x
    P/OCF Ratio27.5x
    PEG Ratio2.4

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 69.5x EBITDA and 44.8x free cash flow.

    EV / Sales3.1x
    EV / EBITDA69.5x
    EV / FCF44.8x

    Price Statistics

    The stock is up 47.93% over 52 weeks and trades 2.99% above its 50-day average.

    Beta (1Y)1.71
    52-Week Change+47.93%
    1-Month Change+10.82%
    3-Month Change+4.71%
    6-Month Change+44.32%
    5-Year Change-28.93%
    10-Year Change+178.53%
    Total Return (1Y)+48.41%
    Total Return (3Y CAGR)+0.41%
    Total Return (5Y CAGR)-5.75%
    Return vs SPY (1Y)+32.77%
    Max Drawdown (1Y)-39.85%
    Max Drawdown (3Y)-68.72%
    Sharpe Ratio (1Y)0.61
    Correlation with SPY (1Y)0.39
    50-Day Average$59.58
    200-Day Average$50.94
    52-Week Range$32.27 to $68.98
    RSI (14 Days)52.1
    Average Volume (20 Days)2.67M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.84x current liabilities.

    Current Ratio1.84x
    Quick Ratio0.90x
    Debt / EBITDA10.87x
    Debt / FCF7.00x

    Returns and Efficiency

    Return on Assets (ROA)-1.99%
    Return on Capital Employed (ROCE)-1.52%
    ROA (5Y Average)5.57%
    ROIC (5Y Average)10.98%
    Asset Turnover0.57x
    Inventory Turnover1.65x
    Receivables Turnover6.33x
    Cash Conversion Cycle238 days

    Scores

    BRKR has an Altman Z-Score of 2.38, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score2.38
    Altman Z ZoneGrey
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $3.51B over the last 12 months is up 2.16% from the 12 months before.

    Revenue$3.51B
    Revenue Growth (YoY)+2.16%
    Gross Profit$1.67B
    Operating Income-$69.80M
    Pretax Income-$70.90M
    Net Income-$115.70M
    EBITDA$157.60M
    EBIT-$70.90M
    Reported EPS (TTM)$1.95

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$119.70M
    Total Debt$1.71B
    Net Debt$1.59B
    Net Debt Per Share$10.45
    Working Capital$985.00M
    Shareholder Equity$0
    Tangible Book Value-$2.15B
    Total Assets$5.83B
    Total Liabilities$3.49B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $97.10M of capital spending, operating cash flow left $244.70M of free cash flow.

    Operating Cash Flow$341.80M
    Capital Expenditures$97.10M
    Free Cash Flow$244.70M
    FCF Per Share$1.61
    Depreciation and Amortization$228.50M
    Dividends Paid$73.40M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1.99%, against a 5-year average of 11.69%.

    Gross Margin47.66%
    Operating Margin-1.99%
    Pretax Margin-2.02%
    Net Margin-3.29%
    EBITDA Margin4.49%
    EBIT Margin-2.02%
    FCF Margin6.97%
    Gross Margin (5Y Average)49.52%
    Operating Margin (5Y Average)11.69%
    Net Margin (5Y Average)8.20%

    Growth

    Revenue grew 10.74% a year over 3 years, and EPS fell 7.87% a year.

    Revenue Growth (3Y CAGR)+10.74%
    Revenue Growth (5Y CAGR)+11.57%
    EPS Growth (3Y CAGR)-7.87%
    EPS Growth (5Y CAGR)+6.27%
    FCF Growth (3Y CAGR)-33.19%
    FCF Growth (5Y CAGR)-28.70%
    Operating Income Growth (3Y CAGR)-45.98%

    Revenue and profit by year

    Dividends and Yields

    BRKR pays out 8.92% of earnings as dividends.

    Dividend Per Share (Annual)$0.20
    Dividend Yield0.33%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)0.00%
    Dividend Growth (5Y CAGR)+4.56%
    Payout Ratio8.92%
    FCF Payout Ratio12.06%
    Earnings Yield3.17%
    FCF Yield2.62%
    Buyback Yield-0.04%
    Shareholder Yield0.27%

    Full dividend history

    Peer Position

    Against 9 similar companies, BRKR has the 3rd highest P/E.

    P/E Ratio31.5x vs 23.6x median
    P/S Ratio2.7x vs 3.5x median
    Revenue Growth (Trailing 4 Quarters, YoY)+2.16% vs +7.55% median
    Dividend Yield0.33% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.61% and EPS growth at 15.18% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.61%
    EPS Growth Forecast (2Y CAGR)+15.18%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BRKR

    What is BRKR's market cap?

    Bruker has a market cap of $9.41B. Its enterprise value, which adds debt and subtracts cash, is $11.00B.

    What is BRKR's P/E ratio?

    Bruker has a trailing P/E ratio of 31.5x and a forward P/E of 28.1x.

    How many shares of BRKR are outstanding?

    Bruker has 152.50M shares outstanding. The count is up 0.46% from a year earlier.

    Does BRKR pay a dividend?

    Yes. Bruker pays $0.20 a share a year, a dividend yield of 0.33%.

    How much debt does BRKR have?

    Bruker has $1.71B of total debt and $119.70M of cash and equivalents, a net debt position of $1.59B.